Investment
Features
FeesSafety
Academy
More
Pluang+

Compare O'Reilly Automotive Inc. Common Stock (ORLY) vs BIO-TECHNE Corp (TECH) Price & Performance

O'Reilly Automotive Inc. Common StockTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

O'Reilly Automotive Inc. Common Stock vs BIO-TECHNE Corp — how do they compare? O'Reilly Automotive Inc. Common Stock trades at $86.25 (market cap $69.58B), while BIO-TECHNE Corp trades at $72.44 (market cap $11.36B). The key difference: O'Reilly Automotive Inc. Common Stock is far larger — about 6.1× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while O'Reilly Automotive Inc. Common Stock pays none. Which is the better fit depends on your goals.

ORLYTECH
Market Cap
$69.58B$11.36B
Volume
4,819,0725,390,331
Sector
Consumer CyclicalHealth
52-Week High
$103.05$72.61
52-Week Low
$82.73$43.31
Enterprise Value
$78.90B$11.39B
Typical Hold Time
—63 Days
Dividend Yield
—0.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

O'Reilly Automotive Inc. Common Stock

No Aura AI signal available yet.

BIO-TECHNE Corp

Bio-Techne (TECH) trades at $72.47, down 0.08% on the day, near its 52-week high of $72.70 (Defense World, 2026-09-28). The stock shows a bullish technical trend with strong moving average signals. Recent shareholder approval of the acquisition by Merck KGaA at $73.00 per share (PRNewsWire, 2026-09-23) is a key catalyst. Q2 2026 earnings beat expectations with EPS of $0.52 versus $0.519 expected, though net income margin has declined from 25.09% in 2023 to 14.96% in 2026.

The pending acquisition offers a near-term upside to the current price, but high valuation ratios (P/E of 62.46, P/S of 9.36) pose a risk if the deal faces regulatory hurdles. Analyst consensus is mixed with 46% Buy and 54% Hold ratings. The stock presents a favorable risk-reward for investors seeking a takeover arbitrage opportunity, with the primary risk being deal failure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About O'Reilly Automotive Inc. Common Stock

O'Reilly Automotive sells automotive aftermarket parts, tools, supplies, equipment, and accessories. It serves both professional service providers and do-it-yourself customers through its store network.

Read more on ORLY →

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH →